Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ACON | US
0.04
1.15%
Healthcare
Health Information Services
30/06/2024
04/06/2026
3.53
3.49
3.61
3.48
Aclarion Inc. a healthcare technology company leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. The company develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM a clinical decision support software. The company was formerly known as Nocimed Inc. and changed its name to Aclarion Inc. in December 2021. Aclarion Inc. was founded in 2008 and is based in Broomfield Colorado.
View LessLow Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
34.4%1 month
37.5%3 months
59.5%6 months
115.4%-
-
1.09
0.47
0.25
-0.56
25.81
-
-4.53M
35.46M
35.46M
-
-10.35K
-
-35.70
-714.18
0.47
2.61
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.73
Range1M
0.73
Range3M
1.06
Rel. volume
0.58
Price X volume
168.49K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| STAR EQUITY HOLDINGS INC | STRR | Diagnostics & Research | 11.65 | 37.53M | 0.87% | n/a | 26.85% |
| Biomerica Inc | BMRA | Diagnostics & Research | 2.145 | 36.08M | 1.66% | n/a | 13.22% |
| Precipio Inc | PRPO | Diagnostics & Research | 23.36 | 34.62M | -2.83% | n/a | 9.66% |
| MDxHealth SA | MDXH | Diagnostics & Research | 0.6 | 28.37M | -0.56% | n/a | -643.01% |
| Cytosorbents Corporation | CTSO | Diagnostics & Research | 0.488 | 26.56M | -0.20% | n/a | 159.92% |
| bioAffinity Technologies Inc. | BIAF | Diagnostics & Research | 1.88 | 25.36M | 11.24% | n/a | 40.20% |
| BioTelemetry Inc | BEAT | Diagnostics & Research | 0.9055 | 24.05M | 1.68% | n/a | 0.00% |
| MYnd Analytics Inc | MYND | Diagnostics & Research | 0.451 | 20.59M | -1.31% | n/a | 117.50% |
| OPAD | OPAD | Real Estate Services | 0.74 | 20.24M | -2.75% | n/a | 406.11% |
| La Rosa Holdings Corp. Common Stock | LRHC | Real Estate Services | 1.1 | 19.60M | -9.09% | n/a | 76.18% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| White Energy Company Limited | WECFF | Coal | 0.1432 | 28.49M | n/a | -2054.06% | |
| Tantech Holdings Ltd | TANH | Coal | 0.4251 | 3.55M | -5.18% | 0.09 | 6.96% |
| Watford Holdings Ltd | WTRE | Insurance - Diversified | 26.577 | 0 | 1.30% | n/a |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.56 | 15.88 | Cheaper |
| Ent. to Revenue | 25.81 | 14.90 | Expensive |
| PE Ratio | - | 64.03 | - |
| Price to Book | 1.09 | 6.17 | Cheaper |
| Dividend Yield | - | 1.35 | - |
| Std. Deviation (3M) | 59.47 | 64.72 | Par |
| Debt to Equity | 0.47 | 0.44 | Par |
| Debt to Assets | 0.25 | 0.35 | Cheaper |
| Market Cap | 35.46M | 3.23B | Emerging |